- Home
- RARE vs ALGM Comparison
RARE vs ALGM Comparison
Compare RARE & ALGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RARE
- ALGM
- Stock Information
- Founded
- RARE 2010
- ALGM 1990
- Country
- RARE United States
- ALGM United States
- Employees
- RARE N/A
- ALGM N/A
- Industry
- RARE Biotechnology: Pharmaceutical Preparations
- ALGM Semiconductors
- Sector
- RARE Health Care
- ALGM Technology
- Exchange
- RARE Nasdaq
- ALGM Nasdaq
- Market Cap
- RARE 4.2B
- ALGM 4.0B
- IPO Year
- RARE 2014
- ALGM 2020
- Fundamental
- Price
- RARE $42.59
- ALGM $26.61
- Analyst Decision
- RARE Strong Buy
- ALGM Strong Buy
- Analyst Count
- RARE 15
- ALGM 9
- Target Price
- RARE $93.13
- ALGM $30.22
- AVG Volume (30 Days)
- RARE 656.5K
- ALGM 2.9M
- Earning Date
- RARE 02-13-2025
- ALGM 01-30-2025
- Dividend Yield
- RARE N/A
- ALGM N/A
- EPS Growth
- RARE N/A
- ALGM N/A
- EPS
- RARE N/A
- ALGM N/A
- Revenue
- RARE $560,230,000.00
- ALGM $772,763,000.00
- Revenue This Year
- RARE $19.26
- ALGM N/A
- Revenue Next Year
- RARE $36.92
- ALGM $17.73
- P/E Ratio
- RARE N/A
- ALGM N/A
- Revenue Growth
- RARE 29.01
- ALGM N/A
- 52 Week Low
- RARE $37.02
- ALGM $18.59
- 52 Week High
- RARE $60.37
- ALGM $33.26
- Technical
- Relative Strength Index (RSI)
- RARE 44.76
- ALGM 60.82
- Support Level
- RARE $41.73
- ALGM $22.99
- Resistance Level
- RARE $44.98
- ALGM $25.55
- Average True Range (ATR)
- RARE 1.72
- ALGM 1.30
- MACD
- RARE -0.04
- ALGM 0.29
- Stochastic Oscillator
- RARE 18.03
- ALGM 74.03
About RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.
About ALGM Allegro MicroSystems Inc.
Allegro Microsystems Inc is a designer, developer, fabless manufacturer, and marketer of sensor ICs and application-specific analog power ICs for automotive and industrial markets. Its Sensor IC allows customers to precisely measure motion, speed, position, and current, and Power ICs include high-temperature and high-voltage capable motor drivers, power management, and LED driver ICs. Its products are divided into three categories such as SENSE which includes Current Sensors, Switches and Latches, and Interface ICs among others; REGULATE which includes Regulators, ClearPower Modules, and LED Drivers; and DRIVE which includes BLDC Drivers, Brush DC, and others. Key revenue for the company is generated from Greater China and the rest from the United States, Japan, Europe, and other regions.